These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1322119)

  • 1. Reduced clonidine rapid eye movement sleep suppression in patients with primary major affective illness.
    Schittecatte M; Charles G; Machowski R; Garcia-Valentin J; Mendlewicz J; Wilmotte J
    Arch Gen Psychiatry; 1992 Aug; 49(8):637-42. PubMed ID: 1322119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of the 'clonidine REM suppression test (CREST)' to separate patients with major depression from controls; a comparison with three currently proposed biological markers of depression.
    Schittecatte M; Garcia-Valentin J; Charles G; Machowski R; Pena-Othaitz MJ; Mendlewicz J; Wilmotte J
    J Affect Disord; 1995 Mar; 33(3):151-7. PubMed ID: 7790666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential response of rapid eye movement sleep to cholinergic blockade by scopolamine in currently depressed, remitted, and normal control subjects.
    Poland RE; McCracken JT; Lutchmansingh P; Lesser IM; Tondo L; Edwards C; Boone KB; Lin KM
    Biol Psychiatry; 1997 May; 41(9):929-38. PubMed ID: 9110098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cholinergic rapid eye movement induction test with arecoline in depression.
    Gillin JC; Sutton L; Ruiz C; Kelsoe J; Dupont RM; Darko D; Risch SC; Golshan S; Janowsky D
    Arch Gen Psychiatry; 1991 Mar; 48(3):264-70. PubMed ID: 1996921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid eye movement sleep eye movements in schizophrenia and depression.
    Benson KL; Zarcone VP
    Arch Gen Psychiatry; 1993 Jun; 50(6):474-82. PubMed ID: 8498882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic regulation of mood and REM sleep: potential model and marker of vulnerability to affective disorder.
    Sitaram N; Nurnberger JI; Gershon ES; Gillin JC
    Am J Psychiatry; 1982 May; 139(5):571-6. PubMed ID: 7072840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic REM induction response: separation of anxiety and depression.
    Dubé S; Kumar N; Ettedgui E; Pohl R; Jones D; Sitaram N
    Biol Psychiatry; 1985 Apr; 20(4):408-18. PubMed ID: 3978173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cholinergic rapid eye movement sleep induction test with RS-86. State or trait marker of depression?
    Berger M; Riemann D; Höchli D; Spiegel R
    Arch Gen Psychiatry; 1989 May; 46(5):421-8. PubMed ID: 2712660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blunted growth hormone response to clonidine in patients with generalized anxiety disorder.
    Abelson JL; Glitz D; Cameron OG; Lee MA; Bronzo M; Curtis GC
    Arch Gen Psychiatry; 1991 Feb; 48(2):157-62. PubMed ID: 1989571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical sleep inhibition by central alpha-adrenoceptor stimulant clonidine antagonized by alpha-receptor blocker yohimbine.
    Putkonen PT; Leppävuori A; Stenberg D
    Life Sci; 1977 Oct; 21(8):1059-65. PubMed ID: 199823
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of alpha and beta adrenoceptors in locus coeruleus stimulation-induced reduction in rapid eye movement sleep in freely moving rats.
    Mallick BN; Singh S; Pal D
    Behav Brain Res; 2005 Mar; 158(1):9-21. PubMed ID: 15680190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the involvement of alpha-2 adrenoceptors in the sedation but not REM sleep inhibition by clonidine in the rat.
    Mäkelä JP; Hilakivi IT
    Med Biol; 1986; 64(6):355-60. PubMed ID: 3029520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential inhibitory noradrenergic responses to clonidine in 25 depressed patients and 25 normal control subjects.
    Siever LJ; Uhde TW; Jimerson DC; Lake CR; Silberman ER; Post RM; Murphy DL
    Am J Psychiatry; 1984 Jun; 141(6):733-41. PubMed ID: 6329004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Children with major depression show reduced rapid eye movement latencies.
    Emslie GJ; Rush AJ; Weinberg WA; Rintelmann JW; Roffwarg HP
    Arch Gen Psychiatry; 1990 Feb; 47(2):119-24. PubMed ID: 2302025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal rapid eye movement latencies in schizophrenia.
    Zarcone VP; Benson KL; Berger PA
    Arch Gen Psychiatry; 1987 Jan; 44(1):45-8. PubMed ID: 3800583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent use of REM latency, dexamethasone suppression, clonidine, and apomorphine tests as biological markers of endogenous depression: a pilot study.
    Ansseau M; Scheyvaerts M; Doumont A; Poirrier R; Legros JJ; Franck G
    Psychiatry Res; 1984 Jul; 12(3):261-72. PubMed ID: 6593757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and EEG sleep changes in primary dysthymia and generalized anxiety: a comparison with normal controls.
    Arriaga F; Paiva T
    Neuropsychobiology; 1990-1991; 24(3):109-14. PubMed ID: 2135064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased activation of anterior paralimbic and executive cortex from waking to rapid eye movement sleep in depression.
    Nofzinger EA; Buysse DJ; Germain A; Carter C; Luna B; Price JC; Meltzer CC; Miewald JM; Reynolds CF; Kupfer DJ
    Arch Gen Psychiatry; 2004 Jul; 61(7):695-702. PubMed ID: 15237081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of noradrenergic and GABA-ergic inputs in pedunculopontine tegmentum for regulation of rapid eye movement sleep in rats.
    Pal D; Mallick BN
    Neuropharmacology; 2006 Jul; 51(1):1-11. PubMed ID: 16616214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain noradrenergic activity in wakefulness and paradoxical sleep: the effect of clonidine.
    Gaillard JM
    Neuropsychobiology; 1985; 13(1-2):23-5. PubMed ID: 2993945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.